Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia

被引：0
|
作者：
Alex Kentsis
Casie Reed
Kim L Rice
Takaomi Sanda
Scott J Rodig
Eleni Tholouli
Amanda Christie
Peter J M Valk
Ruud Delwel
Vu Ngo
Jeffery L Kutok
Suzanne E Dahlberg
Lisa A Moreau
Richard J Byers
James G Christensen
George Vande Woude
Jonathan D Licht
Andrew L Kung
Louis M Staudt
A Thomas Look
机构：
[1] Dana-Farber Cancer Institute,Department of Pediatric Oncology
[2] Harvard Medical School,Division of Hematology and Oncology
[3] Children's Hospital Boston,Division of Hematology and Oncology
[4] Harvard Medical School,Department of Pathology
[5] Northwestern University Feinberg School of Medicine,Department of Haematology
[6] Brigham and Women's Hospital,Department of Hematology
[7] Harvard Medical School,Division of Hematopoietic Stem Cell and Leukemia Research
[8] Manchester Royal Infirmary,Department of Biostatistics and Computational Biology
[9] Central Manchester University Hospitals National Health Service Foundation Trust,Department of Research Pharmacology
[10] and Manchester Academic Health Science Centre,Department of Molecular Oncology
[11] Lurie Family Imaging Center,undefined
[12] Dana-Farber Cancer Institute,undefined
[13] Erasmus Medical Center,undefined
[14] City of Hope National Medical Center,undefined
[15] Dana-Farber Cancer Institute,undefined
[16] School of Cancer and Enabling Sciences,undefined
[17] Faculty of Medical and Human Sciences,undefined
[18] University of Manchester,undefined
[19] Pfizer Global Research and Development,undefined
[20] Van Andel Research Institute,undefined
[21] Center for Cancer Research,undefined
[22] National Cancer Institute,undefined
[23] National Institutes of Health,undefined
来源：
Nature Medicine | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This report identifies upregulation of HGF as an autocrine growth pathway in several subsets of AML. Ligand-dependent activation of MET represents a new oncogenic stimulus, and the dynamic regulation of HGF can overcome the effects of MET inhibition. These results suggest that combination treatments may be needed to disrupt this autocrine signaling loop and quell the growth of AML.
引用
收藏
页码：1118 / 1122
页数：4
相关论文
共 50 条
  • [21] Scribble and the Met receptor tyrosine kinase
    Spilker, A.
    Paliouras, G.
    Naujokas, M.
    Fawcett, J.
    Park, M.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [22] An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment
    Grafone, Tiziana
    Palmisano, Michela
    Nicci, Chiara
    Storti, Sergio
    ONCOLOGY REVIEWS, 2012, 6 (01) : 64 - 74
  • [23] High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndrome
    Verstovsek, S
    Estey, E
    Manshouri, T
    Keating, M
    Kantarjian, H
    Giles, FJ
    Albitar, M
    LEUKEMIA & LYMPHOMA, 2001, 42 (03) : 511 - 516
  • [24] The amount of c-kit receptor tyrosine: Kinase predicts outcome in acute myeloid leukemia (AML).
    Del Poeta, G
    Venditti, A
    Maurillo, L
    Buccisano, F
    Abruzzese, E
    Tamburini, A
    Suppo, G
    Del Principe, MI
    Scornajenghi, KA
    Bruno, A
    Cox, MC
    Masi, M
    Amadori, S
    BLOOD, 2001, 98 (11) : 716A - 716A
  • [25] Endothelial cell derived angiocrine support of acute myeloid leukemia targeted by receptor tyrosine kinase inhibition
    Drusbosky, Leylah
    Gars, Eric
    Trujillo, Angelica
    McGee, Christie
    Meacham, Amy
    Wise, Elizabeth
    Scott, Edward W.
    Cogle, Christopher R.
    LEUKEMIA RESEARCH, 2015, 39 (09) : 984 - 989
  • [26] MER RECEPTOR TYROSINE KINASE IS OVER-EXPRESSED IN AND CONTRIBUTES TO ONCOGENESIS IN PEDIATRIC ACUTE MYELOID LEUKEMIA
    Lee-Sherick, Alisa
    Eisenman, Kristen
    Sather, Susan
    McGranahan, Amy
    Schlegel, Jennifer
    Keating, Amy
    Liang, Xiayuan
    Graham, Doug
    PEDIATRIC BLOOD & CANCER, 2012, 58 (07) : 1017 - 1017
  • [27] TRAMETINIB PROMOTES RESPONSE TO TYROSINE KINASE INHIBITORS IN ACUTE MYELOID LEUKEMIA
    Morales, M. L.
    Linares, M.
    Arenas, A.
    Leivas, A.
    Zagorac, I
    Ayala, R.
    Castro, N.
    Rapado, I
    Gomez, G.
    Quintela Fandino, M.
    Martinez Lopez, J.
    HAEMATOLOGICA, 2017, 102 : 79 - 80
  • [28] Expression and activation of c-Met receptor tyrosine kinase in malignant mesothelioma
    Husain, AN
    Krausz, T
    Tretiakova, M
    Kratzke, R
    Ma, PC
    Salgia, R
    MODERN PATHOLOGY, 2005, 18 : 312A - 312A
  • [29] Expression and activation of c-Met receptor tyrosine kinase in malignant mesothelioma
    Husain, AN
    Krausz, T
    Trekiakova, M
    Kratzke, R
    Ma, PC
    Salgia, R
    LABORATORY INVESTIGATION, 2005, 85 : 312A - 312A
  • [30] Activation of Met tyrosine kinase receptor to protect the heart against anthracycline cardiotoxicity
    Gallo, S.
    Ferrauto, G.
    Di Gregorio, E.
    Spilinga, M.
    Bonzano, A.
    Comoglio, P. M.
    Crepaldi, T.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2017, 109 : 31 - 31
12345